(Q38988270)

8 September 2017

title

Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt (English)

1 reference

multicenter clinical trial

8 September 2017

main subject

0 references

0 references

1 reference

1 reference

1 reference

Mohamed A El-Khalawany

1

1 reference

8 September 2017

Hatem Hassan

2

1 reference

8 September 2017

Dalia Shaaban

3

1 reference

8 September 2017

Noha Ghonaim

4

1 reference

8 September 2017

Bayoumi Eassa

5

1 reference

8 September 2017

publication date

16 November 2012

1 reference

European Journal of Pediatrics

8 September 2017

published in

1 reference

8 September 2017

volume

172

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

351-356

1 reference

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Cyclosporine in severe childhood atopic dermatitis: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Low-dose cyclosporin A microemulsion in children with severe atopic dermatitis: clinical and immunological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Atopic eczema: its impact on the family and financial cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Lymphomatoid papulosis in children: experience of five cases and the treatment efficacy of methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00431-012-1893-3

Soluble CD30 and cyclosporine in severe atopic dermatitis

21 January 2018

1 reference

12 December 2020

Cyclosporin A in atopic dermatitis

1 reference

12 December 2020

Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study

1 reference

12 December 2020

Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children

1 reference

12 December 2020

Methotrexate treatment in 13 children with severe plaque psoriasis

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of severe atopic dermatitis in childhood with cyclosporin

1 reference

12 December 2020

Effective treatment with low-dose methotrexate pulses of a child of mixed connective tissue disease with severe myositis refractory to corticosteroid

1 reference

12 December 2020

Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children

1 reference

12 December 2020

Successful treatment of severe atopic dermatitis with methotrexate

1 reference

12 December 2020

Methotrexate for the treatment of adult atopic dermatitis

1 reference

12 December 2020

The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens

1 reference

12 December 2020

Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.

1 reference

12 December 2020

Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis

1 reference

12 December 2020

Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases

1 reference

12 December 2020

10.1007/S00431-012-1893-3

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1003150956

0 references

1 reference